Contraception is the use of any of various methods to prevent pregnancy. Family planning, in contrast, involves the use of contraception or other measures to limit the number of children and plan the timing and spacing of births. Contraception has been used throughout history. Early methods, however, were ineffective (drinking potions or douching) or dangerous and not available to all people. By the middle of the twentieth century, only 13 percent of couples worldwide used effective methods of contraception. By the year 2000, UNICEF estimated that this figure had risen to 50 percent.
Contraceptive use is not equally distributed throughout the world. Most of western Europe, the United States, parts of Latin America, and Oceania demonstrate high levels of use. India, Pakistan, Nigeria, Sudan, Oman, Yemen, Haiti, Guatemala, Bolivia, and nations in sub-Sahara Africa demonstrate low contraceptive use and high fertility. In the past, family planning programs in some countries were, in effect, population control programs. They were often coercive and did not allow families choice. This is changing, as more people want to limit their family size. In some places, such as China, a strict population control policy is still in place.
In l994, the global attendees at the International Conference on Population and Development (ICPD) in Cairo, Egypt, placed family planning within a holistic context of reproductive health, and family planning is now considered to be a human right. Family planning helps save women's lives. Over 585,000 women die every year from unsafe abortion, childbirth, and pregnancy, with 90 percent of the deaths occurring in developing countries. These deaths are largely preventable; and contraception could play a role in preventing them.
Despite advances in contraceptive technologies, there is no single method that suits everyone. In some places, choice is limited and access is difficult, resulting in an unmet need for contraception (the condition of wanting to avoid or delay childbearing, but not using a contraceptive method).
One way to categorize contraceptive technologies is by the duration of protection. There are permanent, long-term, and short-term methods. In addition to these technologies, there are also behavioral methods of contraception. What follows is a list of all contraceptive technologies and behaviors, how they prevent pregnancy, their effectiveness, potential problems or side effects, and whether they also prevent reproductive tract infections (RTIs), hepatitis C, or sexual transmission of HIV (human immunodeficiency virus).
Permanent Methods
The two permanent surgical methods of contraception are 99 to 99.5 percent effective. They do not prevent RTIs, or HIV transmission, and they both involve a risk of infection or bleeding. In male sterilization, or vasectomy, the vas deferens (the tubes that carry the sperm from the testicles to the penis) are blocked or cut. Female sterilization, or tubal ligation, is a surgical procedure in which a woman's fallopian tubes are cut, burnt, or blocked to prevent sperm from reaching and fertilizing the egg.
Long-Acting Methods
None of the long-acting methods protect against RTIs or HIV transmission. IUDs, implants, and injections are 99 percent effective. Oral contraceptive pills are theoretically 99 percent effective, but pregnancies do occur if pills are missed or not taken on time.
IUD. An intrauterine device (IUD) is most often a nonhormonal method of contraception. The IUD is a small plastic or plastic and copper device placed inside a woman's uterus by a trained health care provider, and it protects against pregnancy for up to twelve years. The IUD may increase the risk of RTIs for women who have more than one partner. Side effects include increased cramping and bleeding during monthly periods. Some IUDs contain a hormone (progesterone) to increase their pregnancy protection while decreasing the risk of heavy bleeding. All of the other long-acting contraceptive methods are hormonal method.
Oral Contraceptive Pill. "The Pill" was introduced in the United States in the 1960s. It contains one or two hormones (either estrogen and progesterone together, or progesterone alone) that prevent ovulation and create a hostile environment for sperm. Although there was originally controversy over the health risks of the pill, it is now considered to be relatively safe for nonsmokers. In fact, it may protect against cancer of the ovaries and uterus. Side effects include nausea, breast tenderness, spotting, weight gain, mood changes, and headaches. Women who smoke should not take the pill as it may cause fatal blood clots. The pill's effectiveness is 99.5 percent if used perfectly, but 95 percent in real use.
Contraceptive Implants. Manufactured under the brand name Norplant®, contraceptive implants are silicone rods containing the hormone progesterone. Six of these matchstick-sized rods are placed under the skin of a woman's upper arm. The progesterone is released over time, and the implants remain effective for five years. While the effectiveness of implants is 99 percent, side effects include irregular monthly periods, spotting, acne, headaches, weight gain, and hair loss. Newer implants use one or two rods and may contain more than one hormone.
Hormonal Injections. Progesterone injections are given every two to three months, while those containing estrogen and progesterone are administered monthly. Injections work by stopping ovulation and making the cervical mucus hostile to sperm. Side effects include irregular periods, spotting, weight gain, headaches, depression, loss of libido, and hair loss.
Short-Acting Methods
Somewhat less effective than long-lasting methods, these contraceptives have fewer side effects. They are primarily physical or chemical barriers that also prevent or decrease the chances of transmitting RTIs and HIV.
Male Condom. This type of condom consists of a latex or animal intestine sheath that is placed over the erect penis before intercourse. Effectiveness is about 86 percent, as condoms can tear or slip off. Some people are allergic to latex and cannot use this type of condom. Latex condoms protect against RTIs and HIV infection, while those made from animal intestine do not.
Female Condom. The thin, female condom is plastic, tunnel-shaped device that is closed on one end. The closed end is placed over the cervix. It protects against both RTIs and pregnancy. One advantage of the female condom is that is it controlled by the woman. This feature is particularly important in a relationship where the woman cannot negotiate for safe sex. There are no medical limitations or side effects. At 80 percent effectiveness, the female condom is slightly less effective than the male condom.
Spermicides and Vaginal Barriers. Spermicides are chemicals that kill sperm or immobilize them. They come in many forms, including foaming tablets or suppositories, melting suppositories, foam, melting film, creams, and jellies. All are placed in the vagina prior to intercourse. Some women have allergic reactions to spermicides. Effectiveness is 80 percent. Spermicides can be used alone or in combination with condoms or vaginal barriers. These devices may also protect against RTIs and HIV, but their effectiveness in this regard is as of yet unknown.
Vaginal barriers (diaphragm, cervical cap, and sponge) are inserted in the vagina before inter-course and must be used with spermicides to be effective. A diaphragm is a soft rubber cup that covers the cervix, a cervical cap is a smaller rubber cup that fits right over the cervix, and a contraceptive sponge is a sponge impregnated with spermicide.
Emergency Contraceptive Pills. Also known as morning-after pills or post-coital pills, these are either estrogen and progesterone or progesterone-only pills that are taken within seventy-two hours of unprotected intercourse or in cases of contraception failure (e.g., forgotten pills, condom breakage, or slippage). Taken as directed they reduce the risk of pregnancy by 75 percent. They provide no RTI or HIV protection.
Behavioral Methods
There are a number of ways to prevent pregnancy that rely on human behavior rather than contraceptive technology.
Abstinence. Abstaining from sexual inter-course, whether completely or periodically, is 100 percent effective, but may be difficult to maintain.
Fertility Awareness. There are a variety of methods a woman can use to tell the fertile time of her menstrual cycle. These include calendar calculation, cervical secretions, basal body temperature (BBT), chemical ovulation prediction kits, and cervical changes. All of these methods are used in combination with either barrier methods (during the fertile time) or periodic abstinence (not having intercourse during the fertile time). Effectiveness is approximately 75 to 80 percent. Fertility awareness can also be used to time intercourse in order to facilitate pregnancy.
Lactational Amenorrhea Method (LAM). This is a behavioral method used by women who have recently given birth. It involves simply the use of breastfeeding during the first six months postpartum, and requires that 85 percent of the baby's food be breast milk. During this period and under these conditions, LAM is 100 percent effective. It is also inexpensive, has no hormonal side effects, and benefits the baby.
Future Methods
Methods of contraception being developed include both variations of existing methods and new concepts. Among the modifications of current methods are biodegradable hormonal implants, subdermal hormonal pellets, injectable hormonal "microspheres" (hybrids of injectables and implants), and intravaginal hormonal rings. New methods include male hormonal contraceptive pills, hormonal patches for men and women, and vaccines against sperm, ovum, or hormones. Microbicides—chemicals that kill bacteria and viruses—are also being tested for use alone, or in combination with spermicides for dual protection.
(SEE ALSO: Abstinence; Condoms; Contraception; Family Health; Family Planning Behavior; Maternal and Child Health; Menstrual Cycle; Planned Parenthood; Pregnancy; Reproduction; Sexually Transmitted Diseases; Women's Health)
Bibliography
Casterline, J. B., and Sinding, S. W. (2000). Unmet Need for Family Planning in Developing Countries and Implications for Population Policy. Working Paper #135. New York: Population Council.
Hatcher, R. A.; Rinehart, W.; Blackburn, R.; Geller, J. S. and Shelton, J. D. (1997). The Essentials of Contraceptive Technology. Baltimore, MD: Population Information Communication Programs, Johns Hopkins School of Public Health.
Hatcher, R. A.; Trussell, J.; Stewart, F.; Cates, W.; Stewart, G. K.; Guest, F.; and Kowal, D. (1998). Contraceptive Technology, 17th edition. New York: Ardent Media.
Klein, S.; Miller, S.; Bishop, J.; and Hansen, M. A Book for Midwives: A Manual for Traditional Birth Attendants and Community Midwives. Palo Alto, CA: Hesperian Foundation.
Speroff, L., and Darney, P. (1992). A Clinical Guide for Contraception. Baltimore, MD: Williams and Watkins.
— SUELLEN MILLER